Investigation Overview
June 13, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Asterias Biotherapeutics Inc (NYSEMKT:AST) was announced over potential breaches of fiduciary duties by certain officers and directors at Asterias Biotherapeutics. The investigation by a law firm concerns whether certain Asterias Biotherapeutics officers and directors brea...
You must register (for free) or login to view the entire investigation.